Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Akero Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −12 vs. Q1 2021
- Shares held
- 27.7M
- −3.76M (−11.9%) vs. Q1 2021
- Total value
- $684.2M
- −$229.4M (−25.1%) vs. Q1 2021
- New holders
- 7
- 43 more added
- Sold out
- 19
- 26 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 5 | $533.0K |
| Q3 2025 | 265 | $4.34B |
| Q2 2025 | 257 | $4.92B |
| Q1 2025 | 240 | $3.50B |
| Q4 2024 | 191 | $2.06B |
| Q3 2024 | 168 | $2.09B |
| Q2 2024 | 153 | $1.68B |
| Q1 2024 | 173 | $1.85B |
| Q4 2023 | 157 | $1.38B |
| Q3 2023 | 181 | $2.90B |
| Q2 2023 | 157 | $2.63B |
| Q1 2023 | 156 | $1.84B |
| Q4 2022 | 162 | $2.66B |
| Q3 2022 | 146 | $1.59B |
| Q2 2022 | 113 | $329.6M |
| Q1 2022 | 103 | $499.2M |
| Q4 2021 | 97 | $746.8M |
| Q3 2021 | 103 | $626.0M |
| Q2 2021 | 97 | $684.2M |
| Q1 2021 | 109 | $913.6M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Akero Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 0 | $0 | 0.00% | −85,492−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −43,885−100.0% | Sold out |
| Aviva PLC | 0 | $0 | 0.00% | −39,880−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −27,500−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −11,728−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −8,343−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −7,709−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −7,300−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −7,106−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −6,705−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,034−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −385−100.0% | Sold out |
| Sargent Bickham Lagudis LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −39−100.0% | Sold out |